447 related articles for article (PubMed ID: 28364255)
21. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
[TBL] [Abstract][Full Text] [Related]
22. Proteasome subunit-α type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy.
Feng Y; Jin MY; Liu DW; Wei L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30287505
[TBL] [Abstract][Full Text] [Related]
23. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.
Zhong X; Chung AC; Chen HY; Dong Y; Meng XM; Li R; Yang W; Hou FF; Lan HY
Diabetologia; 2013 Mar; 56(3):663-74. PubMed ID: 23292313
[TBL] [Abstract][Full Text] [Related]
24. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
25. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
[TBL] [Abstract][Full Text] [Related]
26. Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice.
Chen YQ; Wang XX; Yao XM; Zhang DL; Yang XF; Tian SF; Wang NS
J Nephrol; 2012; 25(4):566-76. PubMed ID: 21983986
[TBL] [Abstract][Full Text] [Related]
27. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
28.
Wang B; Yao K; Wise AF; Lau R; Shen HH; Tesch GH; Ricardo SD
Clin Sci (Lond); 2017 Mar; 131(5):411-423. PubMed ID: 28053239
[TBL] [Abstract][Full Text] [Related]
29. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
[TBL] [Abstract][Full Text] [Related]
30. Ets-1 targeted by microrna-221 regulates angiotensin II-induced renal fibroblast activation and fibrosis.
Di J; Jiang L; Zhou Y; Cao H; Fang L; Wen P; Li X; Dai C; Yang J
Cell Physiol Biochem; 2014; 34(4):1063-74. PubMed ID: 25228106
[TBL] [Abstract][Full Text] [Related]
31. circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy.
Peng F; Gong W; Li S; Yin B; Zhao C; Liu W; Chen X; Luo C; Huang Q; Chen T; Sun L; Fang S; Zhou W; Li Z; Long H
Diabetes; 2021 Feb; 70(2):603-615. PubMed ID: 33472945
[TBL] [Abstract][Full Text] [Related]
32. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.
Zhou L; Xu DY; Sha WG; Shen L; Lu GY; Yin X; Wang MJ
J Transl Med; 2015 Nov; 13():352. PubMed ID: 26552447
[TBL] [Abstract][Full Text] [Related]
33. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.
Schäfer S; Linz W; Bube A; Gerl M; Huber J; Kürzel GU; Bleich M; Schmidts HL; Busch AE; Rütten H
Cardiovasc Res; 2003 Nov; 60(2):447-54. PubMed ID: 14613875
[TBL] [Abstract][Full Text] [Related]
34. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
35. Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
Han F; Wang S; Chang Y; Li C; Yang J; Han Z; Chang B; Sun B; Chen L
J Cell Physiol; 2018 Mar; 233(3):2225-2237. PubMed ID: 28695984
[TBL] [Abstract][Full Text] [Related]
36. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
Kang WL; Xu GS
Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
[TBL] [Abstract][Full Text] [Related]
37. Increased aldosterone levels in a model of type 2 diabetes mellitus.
Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
[TBL] [Abstract][Full Text] [Related]
38. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
39. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.
Figarola JL; Loera S; Weng Y; Shanmugam N; Natarajan R; Rahbar S
Diabetologia; 2008 May; 51(5):882-91. PubMed ID: 18317729
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.
Li X; Zeng L; Cao C; Lu C; Lian W; Han J; Zhang X; Zhang J; Tang T; Li M
Exp Cell Res; 2017 Jan; 350(2):327-335. PubMed ID: 27964927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
